FI953479A0 - 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö - Google Patents
1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttöInfo
- Publication number
- FI953479A0 FI953479A0 FI953479A FI953479A FI953479A0 FI 953479 A0 FI953479 A0 FI 953479A0 FI 953479 A FI953479 A FI 953479A FI 953479 A FI953479 A FI 953479A FI 953479 A0 FI953479 A0 FI 953479A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical use
- arylpyrimidine derivatives
- arylpyrimidine
- derivatives
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16722294 | 1994-07-19 | ||
| JP19421994 | 1994-08-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI953479A0 true FI953479A0 (fi) | 1995-07-18 |
| FI953479A FI953479A (fi) | 1996-01-20 |
Family
ID=26491330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI953479A FI953479A (fi) | 1994-07-19 | 1995-07-18 | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5661153A (fi) |
| EP (1) | EP0700908A1 (fi) |
| AU (1) | AU681034B2 (fi) |
| CA (1) | CA2154293A1 (fi) |
| FI (1) | FI953479A (fi) |
| NO (1) | NO952854L (fi) |
| NZ (1) | NZ272591A (fi) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
| US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
| AU716992B2 (en) * | 1996-09-19 | 2000-03-16 | Japan Energy Corporation | Hydroquinone derivative and pharmaceutical use thereof |
| WO1998037068A1 (en) | 1997-02-21 | 1998-08-27 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
| US6117878A (en) * | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
| RU2207337C2 (ru) * | 1998-11-18 | 2003-06-27 | Изаксон Елена Александровна | 6-(3-ацетилфенил)аминоурацил |
| US7427606B2 (en) | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
| US7378400B2 (en) | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
| US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
| US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
| US6670334B2 (en) | 2001-01-05 | 2003-12-30 | University Of Virginia Patent Foundation | Method and compositions for treating the inflammatory response |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| JP4514452B2 (ja) | 2001-10-01 | 2010-07-28 | ユニバーシティ オブ バージニア パテント ファウンデーション | Ａ２ａアゴニスト活性を有する２−プロピルアデノシン・アナログおよびその組成物 |
| WO2003103665A1 (ja) * | 2002-06-06 | 2003-12-18 | 株式会社医薬分子設計研究所 | 抗アレルギー薬 |
| US20060094737A1 (en) * | 2002-09-20 | 2006-05-04 | Sumitomo Pharmaceuticals Co. Ltd. | Novel uracil derivatives and medicinal use thereof |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| AU2005214137B2 (en) * | 2004-02-18 | 2008-05-29 | Astrazeneca Ab | Compounds |
| KR20070007103A (ko) * | 2004-02-18 | 2007-01-12 | 아스트라제네카 아베 | 벤즈아미드 유도체 및 이의 글루코키나아제 활성화제로서의용도 |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| US7576069B2 (en) | 2004-08-02 | 2009-08-18 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
| CN101068825B (zh) | 2004-08-02 | 2013-05-08 | 弗吉尼亚大学专利基金会 | 具有a2a激动剂活性的具有修饰的5＇-核糖基团的2-丙炔基腺苷类似物 |
| US7442687B2 (en) | 2004-08-02 | 2008-10-28 | The University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
| GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| WO2006040527A1 (en) | 2004-10-16 | 2006-04-20 | Astrazeneca Ab | Process for making phenoxy benzamide compounds |
| GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| JP2008542247A (ja) * | 2005-05-24 | 2008-11-27 | アストラゼネカ アクチボラグ | グルコキナーゼモジュレーターとしての２−フェニル置換イミダゾール［４，５ｂ］ピリジン／ピラジンおよびプリン誘導体 |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| NZ575514A (en) * | 2005-07-09 | 2009-11-27 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| JP2009500442A (ja) * | 2005-07-09 | 2009-01-08 | アストラゼネカ アクチボラグ | ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物 |
| US20080234273A1 (en) * | 2005-07-09 | 2008-09-25 | Mckerrecher Darren | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
| US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
| TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
| WO2007120972A2 (en) | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
| US8188063B2 (en) | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
| TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| SA07280576B1 (ar) * | 2006-10-26 | 2011-06-22 | استرازينيكا ايه بي | مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز |
| BRPI0721143A2 (pt) * | 2006-12-21 | 2014-03-11 | Astrazeneca Ab | Forma cristalina do composto processo para a formação da mesma, uso de um composto, método para tratar doenças mediadas por ativador de glicocinase |
| US8058259B2 (en) | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
| EP2324028A2 (en) | 2008-08-04 | 2011-05-25 | AstraZeneca AB | Therapeutic agents 414 |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
| AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5251395A (en) * | 1975-10-21 | 1977-04-25 | Yamanouchi Pharmaceut Co Ltd | Preparation of novel pteridine derivaties |
| JPS5283800A (en) * | 1976-01-01 | 1977-07-12 | Yamanouchi Pharmaceut Co Ltd | Novel pteridine derivative |
| SE416810C (sv) * | 1977-10-14 | 1982-05-11 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| US4452788A (en) * | 1982-04-21 | 1984-06-05 | Warner-Lambert Company | Substituted 8-phenylxanthines |
| FR2531085A1 (fr) * | 1982-07-28 | 1984-02-03 | Adir | Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| GB8929208D0 (en) * | 1989-12-27 | 1990-02-28 | Almirall Lab | New xanthine derivatives |
| IT1240843B (it) * | 1990-05-24 | 1993-12-17 | Malesci Istituto Farmacobiologico | Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione. |
| IL98559A0 (en) * | 1990-06-21 | 1992-07-15 | Schering Corp | Polycyclic guanine derivatives |
| GB9020921D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
| JPH05194424A (ja) | 1991-10-09 | 1993-08-03 | Nikko Kyodo Co Ltd | 新規なピリミジン誘導体及び該誘導体を有効成分とする医薬 |
| JPH06135943A (ja) | 1992-09-14 | 1994-05-17 | Japan Energy Corp | 新規なウラシル誘導体及びそれを有効成分とするアレルギー疾患治療薬 |
-
1995
- 1995-06-05 US US08/463,277 patent/US5661153A/en not_active Expired - Fee Related
- 1995-07-17 NZ NZ272591A patent/NZ272591A/en unknown
- 1995-07-18 NO NO952854A patent/NO952854L/no unknown
- 1995-07-18 FI FI953479A patent/FI953479A/fi unknown
- 1995-07-18 CA CA002154293A patent/CA2154293A1/en not_active Abandoned
- 1995-07-18 AU AU25057/95A patent/AU681034B2/en not_active Ceased
- 1995-07-18 EP EP95305047A patent/EP0700908A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NZ272591A (en) | 1997-05-26 |
| CA2154293A1 (en) | 1996-01-20 |
| AU2505795A (en) | 1996-02-01 |
| US5661153A (en) | 1997-08-26 |
| AU681034B2 (en) | 1997-08-14 |
| NO952854D0 (no) | 1995-07-18 |
| FI953479A (fi) | 1996-01-20 |
| EP0700908A1 (en) | 1996-03-13 |
| NO952854L (no) | 1996-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
| FI961599A (fi) | 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia | |
| EE03486B1 (et) | Pürasool-4-üülbensoüüli derivaadid ja nende kasutamine herbitsiididena | |
| FI955051A0 (fi) | Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö | |
| FI941137A (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
| EE04566B1 (et) | Epotilooni derivaadid ja nende kasutamine meditsiinis | |
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| BR9504060A (pt) | Composto e formulação farmacêutica | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| BR1100824A (pt) | Composto e composição farmacêutica | |
| FI955235A0 (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
| EE9800459A (et) | Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena | |
| NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
| EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
| NO307092B1 (no) | Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding | |
| FI972245A0 (fi) | Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät | |
| DE69704060T2 (de) | Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung | |
| FI965193A (fi) | Triterpeenijohdannainen ja lääkeseos | |
| BR9509688A (pt) | Composto e composição farmacêutica | |
| FI953021A0 (fi) | 4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä | |
| FI964267A (fi) | Porfosyaniini ja CNC-laajennetut porfyriinit | |
| FI943734A0 (fi) | Uudet makrolidit ja niiden käyttö | |
| FI955679A0 (fi) | Piperidiinijohdannaisia, niiden valmistus ja käyttö | |
| EE9800054A (et) | Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena | |
| FI964113A (fi) | Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö |